August Bio News

Catch up on recent highlights as we grow.

August Bioservices raises $65 million

The funding comes two months after August Bioservices completed the first stage of a $64.7 million campus expansion, which included a renovated commercial facility with sterile processing equipment and new laboratory instrumentation.

August Bioservices Secures $65M in Funding to Expand Capacity

Will be used to add an additional sterile injectable filling suite to support high-speed liquid vial filling.

August Bioservices Closes $65M Series B

NASHVILLE, Tenn. – August Bioservices, in conjunction with the State of Tennessee’s Department of Economic and Community...

A US-Based, Injectables-Focused CDMO with Available Capacity and End-to-End Capabilities

Ryan Downey, Director of Customer Operations, outlines August Bioservices’ capabilities for its customers and what it means to work with them.

“3 Key Trends” with Joe Mase

August Bioservices’ Chief Commercial Officer offers his thought leadership.

Pharma & Biopharma Trends CDMOs Face in 2022 and Beyond

Contract Pharma called upon thought leaders across the pharmaceutical services sector to offer insight on key trends influencing the market.

9 people to watch in Nashville business in 2022

These local leaders will be among the top people to watch in Nashville’s business scene this year...

Innovation in the Nashville Region is State of the Art

The Nashville Region is increasingly becoming a nerve center for life sciences, finance and automotive innovators drawn...

Outsourcing Formulation Development & Manufacturing: Meeting Demand for Biologics & Specialty Drugs

Increasing patent expirations of major drugs, the growing burden of chronic diseases, and elevated global awareness of vaccines...

August Bioservices Expands U.S. Biopharma Manufacturing Capabilities

Exploring innovations, challenges, and future horizons in parenteral drug delivery.$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.

August Bioservices Expands U.S. Biopharma Manufacturing Capabilities

$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of...

August Bioservices Closes $23.6 Million Series A Extension to Expand U.S. Biopharma Manufacturing Capabilities

NASHVILLE, Tenn.--(BUSINESS WIRE)-- August Bioservices,LLC, a contract development and manufacturing organization (CDMO)...